ATE225807T1 - Diagnostische verfahren und zusammensetzungen, die bezug nehmen auf proteoglykan-proteine des knorpelobbaus - Google Patents

Diagnostische verfahren und zusammensetzungen, die bezug nehmen auf proteoglykan-proteine des knorpelobbaus

Info

Publication number
ATE225807T1
ATE225807T1 AT95924095T AT95924095T ATE225807T1 AT E225807 T1 ATE225807 T1 AT E225807T1 AT 95924095 T AT95924095 T AT 95924095T AT 95924095 T AT95924095 T AT 95924095T AT E225807 T1 ATE225807 T1 AT E225807T1
Authority
AT
Austria
Prior art keywords
cartilage
diagnostic methods
compositions relating
proteoglycan proteins
proteoglycan
Prior art date
Application number
AT95924095T
Other languages
English (en)
Inventor
Amanda Jane Fosang
Original Assignee
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Melbourne filed Critical Univ Melbourne
Application granted granted Critical
Publication of ATE225807T1 publication Critical patent/ATE225807T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT95924095T 1994-07-07 1995-06-30 Diagnostische verfahren und zusammensetzungen, die bezug nehmen auf proteoglykan-proteine des knorpelobbaus ATE225807T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPM6668A AUPM666894A0 (en) 1994-07-07 1994-07-07 Diagnostic methods and compositions
PCT/AU1995/000395 WO1996001847A1 (en) 1994-07-07 1995-06-30 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown

Publications (1)

Publication Number Publication Date
ATE225807T1 true ATE225807T1 (de) 2002-10-15

Family

ID=3781236

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95924095T ATE225807T1 (de) 1994-07-07 1995-06-30 Diagnostische verfahren und zusammensetzungen, die bezug nehmen auf proteoglykan-proteine des knorpelobbaus

Country Status (8)

Country Link
EP (1) EP0769025B1 (de)
JP (1) JPH10502807A (de)
AT (1) ATE225807T1 (de)
AU (1) AUPM666894A0 (de)
CA (1) CA2194352C (de)
DE (1) DE69528527T2 (de)
DK (1) DK0769025T3 (de)
WO (1) WO1996001847A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE259505T1 (de) * 1996-08-15 2004-02-15 Novartis Pharma Gmbh Test zur quantifizierung von arthritiszustanden
EP0998572A2 (de) 1997-07-25 2000-05-10 Du Pont Pharmaceuticals Company Aggrecan abbauende metalloproteasen
AU8513098A (en) * 1998-07-24 2000-02-14 Du Pont Pharmaceuticals Company Assays and peptide substrate for determining aggrecan degrading metallo proteaseactivity
SE9904236D0 (sv) * 1999-11-22 1999-11-22 Ana Mar Diagnostics Ab Immunoassay
JP2007507516A (ja) * 2003-10-01 2007-03-29 オプティマー・ファーマスーティカルズ・インコーポレイテッド アミノ糖投与による哺乳動物の障害の治療及びアミノ糖の使用
JP6112427B2 (ja) 2012-03-13 2017-04-12 国立大学法人 岡山大学 リジンオリゴマー誘導体及びそれからなる軟骨組織マーカー

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387504A (en) * 1992-09-30 1995-02-07 Merck & Co., Inc. Monospecific antibodies and assay system for detecting stromelysin cleavage products

Also Published As

Publication number Publication date
EP0769025A4 (de) 1999-06-16
CA2194352A1 (en) 1996-01-25
EP0769025B1 (de) 2002-10-09
DE69528527T2 (de) 2003-06-26
JPH10502807A (ja) 1998-03-17
CA2194352C (en) 2007-01-09
DK0769025T3 (da) 2003-02-10
DE69528527D1 (de) 2002-11-14
AUPM666894A0 (en) 1994-07-28
WO1996001847A1 (en) 1996-01-25
EP0769025A1 (de) 1997-04-23

Similar Documents

Publication Publication Date Title
EA200100485A1 (ru) Соединение сдлс и способ его измерения
ATE425253T1 (de) Tribonektine
EA200101037A1 (ru) Соединения и способы для лечения и диагностики рака легкого
EP1427744A4 (de) System zur antikörperexpression und- synthese
NO983431L (no) Anti-klöemidler
EA200301158A1 (ru) Антитела, блокирующие cripto, и их применения
EA199800798A1 (ru) Новые замешенные циклические аминокислоты в качестве фармацевтических агентов
PT868519E (pt) Diagnostico e tratamento de disturbios relacionados com aur-1 e/ou aur-2
PT888271E (pt) Derivados de benzamidina substituidos com derivados de aminoacidos e hidroxiacidos e sua utilizacao como anticoagulantes
EP1555324A4 (de) Defructosylierungsverfahren
ES2171723T3 (es) 3,4-diaril-2-hidroxi-2,5-dihidrofuranos como profarmacos de inhibidores de cox-2.
DE69938183D1 (de) Verwendungen eines borreliaziden epitops des aussermembranproteins c von borrelia burgdorferi (ospc) als impstoff
PT948604E (pt) Produtos e metodos relacionados com pyk2
ATE225807T1 (de) Diagnostische verfahren und zusammensetzungen, die bezug nehmen auf proteoglykan-proteine des knorpelobbaus
DE69609993D1 (de) Calixarene und ihre verwendung für das abtrennen von metallen
DE60226411D1 (de) Verfahren und zusammensetzungen für peptid-, protein- und peptidomimetische synthese
AU2001233913A1 (en) Bcmp 84, a protein associated to breast cancer
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
DE50212280D1 (de) Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren
ES2162912T3 (es) Microparticulas que contienen un gas, agentes que contienen estas, su utilizacion en el diagnostico por ultrasonidos, asi como procedimientos para la produccion de las particulas y de los agentes.
DE59809283D1 (de) Inhibitoren für den urokinaserezeptor
DE69919577D1 (de) Methode zur geschwindigkeitsmessung in knochen
ATE416260T1 (de) Verfahren zur überwachung und modulierung von proteinfaltung
DK0474645T3 (da) Proteinkompleks
PL336897A1 (en) Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties